Question 1

What is medical affairs regulatory writing software?

Accepted Answer

Medical affairs regulatory writing software supports the authoring and review of scientific content inside regulatory submissions: clinical study reports, patient narratives, clinical overviews and summaries, investigator brochures, and the Module 2.5/2.7 content that synthesizes clinical data for regulators. It sits at the intersection of medical writing (scientific accuracy, evidence traceability) and regulatory writing (submission structure, authority-appropriate language). Good software for this work supports both disciplines in one environment with shared libraries and cross-functional review.

Question 2

How is this different from medical writing software?

Accepted Answer

Medical writing software is broader: it supports any scientific writing, including publications, conference materials, and non-submission medical content. Medical affairs regulatory writing software is the submission-focused subset. In Assyro, the same platform handles both uses, since the underlying workflow (evidence-linked drafting, structured review, audit trail) is identical. The distinction matters mostly for pricing and positioning, not for the technology.

Question 3

Can Medical Affairs and Regulatory Affairs work in the same tool?

Accepted Answer

Yes, and they should. The common pattern of Medical Affairs in Veeva MedComms and Regulatory Affairs in Veeva Vault Submissions creates a hard coordination seam that costs days-to-weeks on every cross-functional review. Assyro's approach is one workspace with role-based scoping. Medical and Regulatory staff see their own work but coordinate through shared documents and synchronized review workflows. The review cycles that take 3-4 weeks in the separated-tools pattern typically compress to 4-7 days when both teams work in the same platform.

Question 4

Does Assyro support ICH E6 (R3) clinical documentation?

Accepted Answer

Yes. ICH E6 (R3) finalized in 2024 updated good clinical practice expectations with new structure for clinical trial documentation. Assyro's clinical writing templates align with E6 (R3) including the revised data governance, data integrity, and clinical trial conduct documentation. Teams transitioning from E6 (R2) to R3 can use Assyro's migration patterns to update in-flight protocols and CSRs without rewriting from scratch.

Question 5

How does Medical Affairs benefit from a submission-focused tool?

Accepted Answer

Medical Affairs output ultimately has to land in submissions. Writing medical content in a submission-aware platform means the content is structurally ready for eCTD placement from day one, the citations are already in the format RA needs, and the cross-reference to other submission modules is maintained. Medical Affairs teams using non-submission writing tools find that their output requires significant downstream work to become submission-ready. Starting in a submission-aware platform eliminates that rework.

Question 6

Can multiple writers work on the same CSR concurrently?

Accepted Answer

Yes. Section-level concurrent editing with locking prevents the Word merge conflicts that break multi-writer CSR workflows. A CSR typically has 4-8 contributing writers across clinical, statistical, medical, and safety sections. Each writer works on their section in parallel, and the document assembles from the section modules with a clean audit trail. Review comments route to specific sections and specific reviewers, reducing the 'whose turn is it to have the file open' bottleneck.

Question 7

How does Assyro handle patient narrative generation?

Accepted Answer

Given structured clinical data (SDTM or ADaM datasets), Assyro generates patient narratives that match the sponsor's narrative template, include required adverse event and concomitant medication detail, and preserve consistent language across narratives. For a Phase 3 program with 300-500 patient narratives, this is a significant accelerator: the initial generation completes in hours, and writers review and edit drafts rather than writing from scratch. Narrative consistency across the full set also improves because the template is enforced by construction.

Question 8

Does Assyro integrate with Veeva MedComms?

Accepted Answer

Documents authored in Assyro can publish into Veeva for teams that use Veeva as their medical DMS of record. The pattern is: authoring and review in Assyro (which offers better writing experience and AI-assisted drafting), final documents flow to Veeva for archival and cross-organizational access. This preserves existing Veeva investment while upgrading the authoring experience. Teams with lighter Veeva usage often consolidate to Assyro entirely.

Medical Affairs Regulatory Writing Software

Medical Affairs Workflow Coverage

Draft Clinical Overviews With Linked Evidence From Day One

Align Medical and Regulatory Language Before Final Review

Reuse Approved Clinical Language Across Indications

Cut Medical Affairs Review From 3 Weeks to Under a Week

Medical Affairs Controls and Capacity

Maintain Audit-Ready Team Execution

Manage More Medical Affairs Work Without Growing the Team

Questions About Medical Affairs Workflows

See Medical Affairs Workflows in Assyro.